Roundup Maker to Pay $10 Billion to Settle Cancer Suits (Q112220777)
news article
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Roundup Maker to Pay $10 Billion to Settle Cancer Suits |
news article |
Statements
Roundup Maker to Pay $10 Billion to Settle Cancer Suits (English)
1 reference
Patricia Cohen
0 references
24 June 2020
0 references
1 reference
When Bayer, the giant German chemical and pharmaceutical maker, acquired Monsanto two years ago, the company knew it was also buying the world’s best-known weedkiller. What it didn’t anticipate was a legal firestorm over claims that the herbicide, Roundup, caused cancer.Now Bayer is moving to put those troubles behind it, agreeing to pay more than $10 billion to settle tens of thousands of claims while continuing to sell the product without adding warning labels about its safety. (English)
1 reference
The settlement covers an estimated 95,000 cases and includes $1.25 billion for potential future claims from Roundup customers who may develop the form of cancer known as non-Hodgkin’s lymphoma.The company is taking a calculated risk that the benchmark settlement will largely resolve its legal problems. Bayer still faces at least 30,000 claims from plaintiffs who have not agreed to join the settlement. (English)